Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Newby

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Trends in Cardiovascular Medicine|November 21, 2007
Metalloproteinases and vulnerable atherosclerotic plaquesAndrew C Newby
Vascular Pharmacology|February 14, 2012
Matrix metalloproteinase inhibition therapy for vascular diseasesAndrew C Newby
Circulation Research|November 15, 2005
Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stabilityAndrew C Newby, Jason L Johnson
Current Opinion in Lipidology|September 11, 2009
Macrophage heterogeneity in atherosclerotic plaquesJason L Johnson, Andrew C Newby
Journal of Vascular Research|August 2, 2003
Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodellingAlex J Chase, Andrew C Newby
Journal of Vascular Research|December 18, 2009
Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in miceAnita C Thomas, Andrew C Newby
European Heart Journal|August 15, 2019
Andrew Hurst Henderson, 1930-2017Alan G Fraser, Andrew C Newby
Journal of Cardiac Surgery|March 20, 2003
Gene therapy for all aspects of vein-graft diseaseStephen J White, Andrew C Newby
Cardiovascular Research|January 24, 2006
From tadpole tails to transgenic mice: metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular diseaseAndrew C Newby, Matthias Pauschinger, Francis G Spinale
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2003
Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophagesZhaoxia Luan, Alex J Chase, Andrew C Newby
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Trends in Cardiovascular Medicine|November 21, 2007
Metalloproteinases and vulnerable atherosclerotic plaquesAndrew C Newby
Vascular Pharmacology|February 14, 2012
Matrix metalloproteinase inhibition therapy for vascular diseasesAndrew C Newby
Circulation Research|November 15, 2005
Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stabilityAndrew C Newby, Jason L Johnson
Current Opinion in Lipidology|September 11, 2009
Macrophage heterogeneity in atherosclerotic plaquesJason L Johnson, Andrew C Newby
Journal of Vascular Research|August 2, 2003
Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodellingAlex J Chase, Andrew C Newby
Journal of Vascular Research|December 18, 2009
Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in miceAnita C Thomas, Andrew C Newby
European Heart Journal|August 15, 2019
Andrew Hurst Henderson, 1930-2017Alan G Fraser, Andrew C Newby
Journal of Cardiac Surgery|March 20, 2003
Gene therapy for all aspects of vein-graft diseaseStephen J White, Andrew C Newby
Cardiovascular Research|January 24, 2006
From tadpole tails to transgenic mice: metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular diseaseAndrew C Newby, Matthias Pauschinger, Francis G Spinale
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2003
Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophagesZhaoxia Luan, Alex J Chase, Andrew C Newby
Pageof 11